Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
Epithelial cell states distinguish between uterine cancers
Fri December 3rd - Two epithelial cell states have been identified that can help to distinguish between types of uterine cancer, British researchers announced last night. More
COVID-19 boosters increase immunity
Fri December 3rd - Six different types of COVID-19 boosters are safe and increase immunity following vaccination with either the AstraZeneca or Pfizer-BioNTech jabs, British researchers report today. More
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote: on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...

AIDS-related deaths more than halved

Friday July 18th, 2014

AIDS-related causes of death among adults with HIV have more than halved in 10 years, a study out today has revealed.

A large international study published in The Lancet has found that out of almost 50,000 HIV-positive adults receiving care and antiretroviral therapy (ART) at more than 200 clinics across Europe, USA, and Australia, overall death rates have almost halved since 1999.

Deaths due to AIDS-related causes and cardiovascular disease have declined by about 65%, while liver-related deaths have dropped by more than 50%.

However, over the study period there was no reduction in death rates from non-AIDS cancers, which remained stable over time at 1.6 deaths per 1,000 years 1999-2000 to 2.1 in 2009–2011).

The research is published in a special issue of The Lancet published ahead of AIDS 2014, the international AIDS conference of the IAS, in Melbourne, Australia, and reveals that non-AIDS cancers are now the leading cause of non-AIDS deaths in people with HIV, accounting for 23% of all deaths.

Using data from the Data Collection On Adverse Events Of Anti-HIV Drugs (D:A:D) study, researchers from University College London, England, examined trends in underlying causes of death in people with HIV between 1999 and 2011, who were followed-up for a median of 6 years.

Of the 3,909 deaths that occurred over the study period, about 29% were from an AIDS-related cause. Cancers at 15% - mainly lung cancer – were the most frequent causes of non-AIDS deaths, followed by liver disease at 13% and then and cardiovascular disease (11%).

Mortality decreased from about 17.5 deaths per 1,000 person-years in 1999-2000 to 9.1 deaths per 1,000 years in 2009-2011.

There were similar falls in deaths related to AIDS (5.9 deaths per 1,000 person-years to 2.0), liver disease (2.7 to 0.9), and cardiovascular disease (1.8 to 0.9).

Study leader Dr Colette Smith said: “These recent reductions in rates of AIDS-related deaths are linked with continued improvement in CD4 count and provide further evidence of the substantial net benefits of ART.

“But despite these positive results, AIDS-related disease remains the leading cause of death in this population.

“Continued efforts to ensure good ART adherence and to diagnose more individuals at an earlier stage before the development of severe immunodeficiency are important to ensure that the low death rate from AIDS is sustained and potentially decreased even further.”

Further research is needed to gain a clearer understanding of why the risk of dying from a non-AIDS cancer remains high and to assess the effect of specific antiretroviral drugs on non-AIDS cancer rates, she added.

Smith C J, Ryom L et al. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. The Lancet. 2014; 384: 241–48. [abstract]

Tags: Australia | Europe | Flu & Viruses | North America | World Health

Printer friendly page Printer friendly page

Comment on this article:

<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)